171 related articles for article (PubMed ID: 19413597)
1. p38 mitogen-activated protein kinase (MAPK) is activated by noradrenaline and serves a cardioprotective role, whereas adrenaline induces p38 MAPK dephosphorylation.
Tsang MY; Rabkin SW
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e12-9. PubMed ID: 19413597
[TBL] [Abstract][Full Text] [Related]
2. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
[TBL] [Abstract][Full Text] [Related]
6. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
9. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
10. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress.
Abdelmegeed MA; Kim SK; Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 2004 Aug; 310(2):728-36. PubMed ID: 15051799
[TBL] [Abstract][Full Text] [Related]
11. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.
Szokodi I; Kerkelä R; Kubin AM; Sármán B; Pikkarainen S; Kónyi A; Horváth IG; Papp L; Tóth M; Skoumal R; Ruskoaho H
Circulation; 2008 Oct; 118(16):1651-8. PubMed ID: 18824646
[TBL] [Abstract][Full Text] [Related]
12. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
13. Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2.
Posser T; de Aguiar CB; Garcez RC; Rossi FM; Oliveira CS; Trentin AG; Neto VM; Leal RB
Arch Toxicol; 2007 Jun; 81(6):407-14. PubMed ID: 17333127
[TBL] [Abstract][Full Text] [Related]
14. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
16. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.
Punn A; Mockridge JW; Farooqui S; Marber MS; Heads RJ
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):891-9. PubMed ID: 10970806
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
19. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells.
Glotin AL; Calipel A; Brossas JY; Faussat AM; Tréton J; Mascarelli F
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4614-23. PubMed ID: 17003459
[TBL] [Abstract][Full Text] [Related]
20. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
Chiou WF; Tsai HR; Yang LM; Tsai WJ
Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
